Cell-free microRNAs in blood and other body fluids, as cancer biomarkers

Cell Proliferation

Volumn 49, Issue 3, 2016, Pages 281-303

  Ortiz Quintero, Blanca ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; MICRORNA; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ANGIOGENESIS; ARTICLE; BLOOD; BODY FLUID; CANCER GROWTH; CARCINOGENESIS; CELL FREE SYSTEM; EXOSOME; GENE EXPRESSION REGULATION; HUMAN; IMMUNE RESPONSE; METASTASIS POTENTIAL; NEOPLASM; NONHUMAN; PLASMA; PROMOTER REGION; RNA EDITING; RNA METHYLATION; SERUM; TRANSCRIPTION REGULATION; TUMOR ESCAPE; ANIMAL; CHEMISTRY; GENETICS; NEOPLASM METASTASIS; NEOPLASMS; PATHOLOGY;

ANIMALS; BIOMARKERS, TUMOR; BODY FLUIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84969544869     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12262     Document Type: Article

References (234)

1. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294, 853-858.
2. Baskerville S, Bartel DP (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247.
3. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK et al. (2006) Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125, 887-901.
4. Bohnsack MT, Czaplinski K, Gorlich D (2004) Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10, 185-191.
5. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K et al. (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740-744.
6. Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Radmark O (2002) Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J. 21, 5864-5874.
7. Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat. Rev. Cancer 15, 321-333.
8. Olive V, Minella AC, He L. (2015) Outside the coding genome, mammalian microRNAs confer structural and functional complexity. Sci. Signal. 8, re2.
9. Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H et al. (2008) Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc. Natl Acad. Sci. USA 105, 7964-7969.
10. Zeng Y, Yi R, Cullen BR (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA 100, 9779-9784.
11. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
12. Carthew RW, Sontheimer EJ (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655.
13. Avila-Moreno F, Urrea F, Ortiz-Quintero B (2011) [MicroRNAs in diagnosis and prognosis in lung cancer]. Rev. Invest. Clin. 63, 516-535.
14. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA (2006) Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 21, 533-542.
15. Guil S, Esteller M (2015) RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem. Sci. 40, 248-256.
16. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE et al. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906.
17. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36.
18. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86.
19. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104, 1604-1609.
20. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255-18260.
21. Tang X, Tang G, Ozcan S (2008) Role of microRNAs in diabetes. Biochim. Biophys. Acta 1779, 697-701.
22. Calin GA, Croce CM (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 66, 7390-7394.
23. Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31, 37-49.
24. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299, 425-436.
25. Chen Y, Stallings RL (2007) Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 67, 976-983.
26. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901-1908.
27. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl Acad. Sci. USA 108, 3713-3718.
28. Wei L, Lian B, Zhang Y, Li W, Gu J, He X et al. (2014) Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma. BMC Genomics 15(Suppl 1), S13.
29. Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC et al. (2014) miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res. 74, 751-764.
30. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H et al. (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 69, 5776-5783.
31. Avery-Kiejda KA, Braye SG, Mathe A, Forbes JF, Scott RJ (2014) Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer 14, 51.
32. Vergho D, Kneitz S, Rosenwald A, Scherer C, Spahn M, Burger M et al. (2014) Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC Cancer 14, 25.
33. Gordillo GM, Biswas A, Khanna S, Pan X, Sinha M, Roy S et al. (2014) Dicer knockdown inhibits endothelial cell tumor growth via microRNA 21a-3p targeting of Nox-4. J. Biol. Chem. 289, 9027-9038.
34. Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V et al. (2014) MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell 25, 469-483.
35. Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL et al. (2014) miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clin. Cancer Res. 20, 6559-6569.
36. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S et al. (2008) Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283, 33394-33405.
37. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I et al. (2009) MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc. Natl Acad. Sci. USA 106, 12085-12090.
38. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513-10518.
39. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ et al. (2010) The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741.
40. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D et al. (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 28, 655-661.
41. Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim ST et al. (2013) Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Int. J. Cancer 133, 645-652.
42. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006.
43. Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H et al. (2013) Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS ONE 8, e75184.
44. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95.
45. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl Acad. Sci. USA 108, 5003-5008.
46. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233.
47. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3, e3148.
48. Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D (2009) Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ. Health Perspect. 117, 1745-1751.
49. Zhang B, Pan X (2009) RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect. 117, 231-240.
50. Vrijens K, Bollati V, Nawrot TS (2015) MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ. Health Perspect. 123, 399-411.
51. Hou L, Barupal J, Zhang W, Zheng Y, Liu L, Zhang X et al. (2016) Particulate air pollution exposure and expression of viral and human microRNAs in blood: The Beijing Truck Driver Air Pollution Study. Environ. Health Perspect. 124, 344-350.
52. Yamamoto M, Singh A, Sava F, Pui M, Tebbutt SJ, Carlsten C (2013) MicroRNA expression in response to controlled exposure to diesel exhaust: attenuation by the antioxidant N-acetylcysteine in a randomized crossover study. Environ. Health Perspect. 121, 670-675.
53. Bollati V, Marinelli B, Apostoli P, Bonzini M, Nordio F, Hoxha M et al. (2010) Exposure to metal-rich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes. Environ. Health Perspect. 118, 763-768.
54. Takahashi K, Yokota SI, Tatsumi N, Fukami T, Yokoi T, Nakajima M. (2013) Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol. Appl. Pharmacol. 272, 154-160
55. Huang J, Wu J, Li Y, Li X, Yang T, Yang Q et al. (2014) Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer. Biomed. Res. Int. 2014, 364316.
56. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833-840.
57. Kannan M, Atreya C (2010) Differential profiling of human red blood cells during storage for 52 selected microRNAs. Transfusion 50, 1581-1588.
58. Chen SY, Wang Y, Telen MJ, Chi JT (2008) The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS ONE 3, e2360.
59. Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C et al. (2012) Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer 130, 1620-1628.
60. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L et al. (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med. 3, 495-503.
61. Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W (2011) Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J. Surg. Oncol. 104, 847-851.
62. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721-1726.
63. Wang F, Zheng Z, Guo J, Ding X (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol. Oncol. 119, 586-593.
64. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C et al. (2011) A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer 47, 784-791.
65. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK et al. (2012) High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol. 29, 618-626.
66. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT et al. (2012) Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS ONE 7, e32307.
67. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg. 251, 499-505.
68. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H (2010) Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 12, R90.
69. Eichelser C, Flesch-Janys D, Chang-Claude J, Pantel K, Schwarzenbach H (2013) Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin. Chem. 59, 1489-1496.
70. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B (2009) Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 4, e6229.
71. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112, 55-59.
72. Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T et al. (2009) MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 14, 529-538.
73. Zhang C, Wang C, Chen X, Yang C, Li K, Wang J et al. (2010) Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin. Chem. 56, 1871-1879.
74. Sanfiorenzo C, Ilie MI, Belaid A, Barlesi F, Mouroux J, Marquette CH et al. (2013) Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS ONE 8, e54596.
75. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab. Invest. 91, 579-587.
76. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10, 42-46.
77. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S (2010) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 5, e13735.
78. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B et al. (2012) Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106, 768-774.
79. Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC et al. (2012) Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 72, 1469-1477.
80. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M et al. (2013) Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin. Cancer Res. 19, 1213-1224.
81. Adam L, Wszolek MF, Liu CG, Jing W, Diao L, Zien A et al. (2013) Plasma microRNA profiles for bladder cancer detection. Urol. Oncol. 31, 1701-1708.
82. Ho AS, Huang X, Cao H, Christman-Skieller C, Bennewith K, Le QT et al. (2010) Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol. 3, 109-113.
83. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 102, 1174-1179.
84. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z et al. (2011) Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 29, 4781-4788.
85. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L et al. (2012) Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS ONE 7, e44398.
86. Li BX, Yu Q, Shi ZL, Li P, Fu S (2015) Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival. Int. J. Clin. Exp. Med. 8, 7241-7250.
87. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118-126.
88. Komatsu S, Ichikawa D, Takeshita H, Konishi H, Nagata H, Hirajima S et al. (2012) Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin. Biol. Ther. 12(Suppl 1), S53-S59.
89. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H et al. (2011) Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 105, 104-111.
90. Cortez MA, Calin GA (2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 9, 703-711.
91. Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H et al. (2013) Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer 119, 1618-1626.
92. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E et al. (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 15, 5473-5477.
93. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC et al. (2012) miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin. Cancer Res. 18, 4713-4724.
94. Sadakari Y, Ohtsuka T, Ohuchida K, Tsutsumi K, Takahata S, Nakamura M et al. (2010) MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma. JOP 11, 587-592.
95. Hanson EK, Lubenow H, Ballantyne J (2009) Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal. Biochem. 387, 303-314.
96. Tolle A, Jung M, Rabenhorst S, Kilic E, Jung K, Weikert S (2013) Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer. Oncol. Rep. 30, 1949-1956.
97. Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ et al. (2012) An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br. J. Cancer 107, 123-128.
98. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S et al. (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 102, 522-529.
99. von Brandenstein M, Pandarakalam JJ, Kroon L, Loeser H, Herden J, Braun G et al. (2012) MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am. J. Pathol. 180, 1787-1797.
100. Rehbein G, Schmidt B, Fleischhacker M (2015) Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer. Clin. Chim. Acta 450, 78-82.
101. Kim JO, Gazala S, Razzak R, Guo L, Ghosh S, Roa WH et al. (2015) Non-small cell lung cancer detection using microRNA expression profiling of bronchoalveolar lavage fluid and sputum. Anticancer Res. 35, 1873-1880.
102. Shin YM, Yun J, Lee OJ, Han HS, Lim SN, An JY et al. (2014) Diagnostic value of circulating extracellular miR-134, miR-185, and miR-22 levels in lung adenocarcinoma-associated malignant pleural effusion. Cancer Res. Treat. 46, 178-185.
103. Wang T, Lv M, Shen S, Zhou S, Wang P, Chen Y et al. (2012) Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS ONE 7, e43268.
104. Xie L, Chen X, Wang L, Qian X, Wang T, Wei J et al. (2010) Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer 10, 591.
105. Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K et al. (2015) Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS ONE 10, e0130472.
106. Wang J, Raimondo M, Guha S, Chen J, Diao L, Dong X et al. (2014) Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic cancer. J. Cancer 5, 696-705.
107. Shi R, Wang PY, Li XY, Chen JX, Li Y, Zhang XZ et al. (2015) Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget 6, 26971-26981.
108. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S et al. (2013) MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS ONE 8, e78115.
109. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659.
110. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433.
111. Wang K, Zhang S, Weber J, Baxter D, Galas DJ (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259.
112. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452.
113. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL et al. (2010) Functional delivery of viral miRNAs via exosomes. Proc. Natl Acad. Sci. USA 107, 6328-6333.
114. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 70, 9621-9630.
115. Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G et al. (2014) HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat. Commun. 5, 3292.
116. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476.
117. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmedov NB et al. (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 4, e4722.
118. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D et al. (2010) Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5, e13515.
119. Goldie BJ, Dun MD, Lin M, Smith ND, Verrills NM, Dayas CV et al. (2014) Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons. Nucleic Acids Res. 42, 9195-9208.
120. Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS, Zhang XS et al. (2014) Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget 5, 5439-5452.
121. van Niel G, Porto-Carreiro I, Simoes S, Raposo G (2006) Exosomes: a common pathway for a specialized function. J. Biochem. 140, 13-21.
122. Lee Y, El Andaloussi S, Wood MJ (2012) Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet. 21, R125-R134.
123. Segura E, Nicco C, Lombard B, Veron P, Raposo G, Batteux F et al. (2005) ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106, 216-223.
124. Raiborg C, Stenmark H (2009) The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458, 445-452.
125. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A et al. (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14, 677-685.
126. Nabhan JF, Hu R, Oh RS, Cohen SN, Lu Q (2012) Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc. Natl Acad. Sci. USA 109, 4146-4151.
127. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143-1149.
128. Li L, Zhu D, Huang L, Zhang J, Bian Z, Chen X et al. (2012) Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS ONE 7, e46957.
129. Lv Z, Wei Y, Wang D, Zhang CY, Zen K, Li L (2014) Argonaute 2 in cell-secreted microvesicles guides the function of secreted miRNAs in recipient cells. PLoS ONE 9, e103599.
130. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N et al. (2013) Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980.
131. Iguchi H, Kosaka N, Ochiya T (2010) Secretory microRNAs as a versatile communication tool. Commun. Integr. Biol. 3, 478-481.
132. Wagner J, Riwanto M, Besler C, Knau A, Fichtlscherer S, Roxe T et al. (2013) Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler. Thromb. Vasc. Biol. 33, 1392-1400.
133. Pepe MS (2000) An interpretation for the ROC curve and inference using GLM procedures. Biometrics 56, 352-359.
134. Yang Q, Jia C, Wang P, Xiong M, Cui J, Li L et al. (2014) MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. Int. J. Cardiol. 177, 925-934.
135. Cengiz M, Karatas OF, Koparir E, Yavuzer S, Ali C, Yavuzer H et al. (2015) Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore) 94, e693.
136. Prabu P, Rome S, Sathishkumar C, Aravind S, Mahalingam B, Shanthirani CS et al. (2015) Circulating MiRNAs of 'Asian Indian Phenotype' identified in subjects with impaired glucose tolerance and patients with type 2 diabetes. PLoS ONE 10, e0128372.
137. Lian F, Cui Y, Zhou C, Gao K, Wu L (2015) Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS ONE 10, e0121499.
138. Hou B, Ishinaga H, Midorikawa K, Shah SA, Nakamura S, Hiraku Y et al. (2015) Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma. Cancer Biol. Ther. 16, 1042-1046.
139. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY (2012) Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol. 33, 1933-1942.
140. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF (2011) Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS ONE 6, e28486.
141. Wong TS, Ho WK, Chan JY, Ng RW, Wei WI (2009) Mature miR-184 and squamous cell carcinoma of the tongue. ScientificWorldJournal 9, 130-132.
142. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H et al. (2012) Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br. J. Cancer 106, 740-747.
143. Nonaka R, Miyake Y, Hata T, Kagawa Y, Kato T, Osawa H et al. (2015) Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Int. J. Oncol. 47, 1097-1102.
144. Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, Chen YQ et al. (2014) Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J. Hematol. Oncol. 7, 6.
145. Le HB, Zhu WY, Chen DD, He JY, Huang YY, Liu XG et al. (2012) Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med. Oncol. 29, 3190-3197.
146. Li J, Liu Y, Wang C, Deng T, Liang H, Wang Y et al. (2015) Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma. Sci. Rep. 5, 12921.
147. Singh R, Pochampally R, Watabe K, Lu Z, Mo YY (2014) Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol. Cancer. 13, 256.
148. Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K et al. (2014) MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer. Oncol. Rep. 31, 1832-1838.
149. Hakami F, Darda L, Stafford P, Woll P, Lambert DW, Hunter KD (2014) The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC). Br. J. Cancer 111, 807-816.
150. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H et al. (2010) MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 285, 7986-7994.
151. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688.
152. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR et al. (2014) Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25, 501-515.
153. Krichevsky AM, Gabriely G (2009) miR-21: a small multi-faceted RNA. J. Cell Mol. Med. 13, 39-53.
154. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658.
155. Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282, 14328-14336.
156. Ma J, Yao Y, Wang P, Liu Y, Zhao L, Li Z et al. (2014) MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kruppel-like factor 4. Cancer Lett. 355, 85-95.
157. Su Y, Wang Y, Zhou H, Lei L, Xu L (2014) MicroRNA-152 targets ADAM17 to suppress NSCLC progression. FEBS Lett. 588, 1983-1988.
158. Cheng Z, Ma R, Tan W, Zhang L (2014) MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2. Exp. Mol. Med. 46, e112.
159. Zhai R, Kan X, Wang B, Du H, Long Y, Wu H et al. (2014) miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151. Tumour Biol. 35, 11367-11373.
160. Dang YW, Zeng J, He RQ, Rong MH, Luo DZ, Chen G (2014) Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac. J. Cancer Prev. 15, 4969-4976.
161. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V et al. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862-876.
162. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ et al. (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res. 71, 3552-3562.
163. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201.
164. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS et al. (2011) Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol. Med. 3, 279-290.
165. Pekarsky Y, Croce CM (2010) Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget 1, 224-227.
166. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292.
167. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
168. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904.
169. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
170. Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196.
171. Nieto MA (2013) Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850.
172. Ceppi P, Peter ME (2014) MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells. Oncogene 33, 269-278.
173. Lamouille S, Subramanyam D, Blelloch R, Derynck R (2013) Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 25, 200-207.
174. Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR et al. (2014) Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann. Surg. 259, 735-743.
175. Chung VY, Tan TZ, Tan M, Wong MK, Kuay KT, Yang Z et al. (2016) GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification. Sci. Rep. 6, 19943.
176. Zhang HF, Alshareef A, Wu C, Li S, Jiao JW, Cao HH et al. (2015) Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin beta1/AKT pathway in esophageal squamous cell carcinoma: an E-cadherin-independent mechanism. Oncotarget 6, 28949-28960.
177. Rhodes LV, Martin EC, Segar HC, Miller DF, Buechlein A, Rusch DB et al. (2015) Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget 6, 16638-16652.
178. Cong N, Du P, Zhang A, Shen F, Su J, Pu P et al. (2013) Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol. Rep. 29, 1579-1587.
179. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601.
180. Feng X, Wang Z, Fillmore R, Xi Y (2014) MiR-200, a new star miRNA in human cancer. Cancer Lett. 344, 166-173.
181. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J et al. (2013) MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 62, 1315-1326.
182. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273.
183. Imaoka H, Toiyama Y, Okigami M, Yasuda H, Saigusa S, Ohi M et al. (2015) Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Gastric Cancer Aug. 2 [Epub 2015/08/04]
184. Ren ZG, Dong SX, Han P, Qi J (2016) miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer. Oncol. Rep. 35, 1365-1374.
185. Stuckrath I, Rack B, Janni W, Jager B, Pantel K, Schwarzenbach H (2015) Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget 6, 13387-13401.
186. Zou CD, Zhao WM, Wang XN, Li Q, Huang H, Cheng WP et al. (2016) MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma. Oncotarget 7, 266-278.
187. Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S et al. (2016) Examining plasma microRNA markers for colorectal cancer at different stages. Oncotarget 7, 11434-11449.
188. Madhavan D, Peng C, Wallwiener M, Zucknick M, Nees J, Schott S et al. (2016) Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis. Carcinogenesis 2016 Jan 19. pii: bgw008. [Epub ahead of print]
189. Zhou R, Zhou X, Yin Z, Guo J, Hu T, Jiang S et al. (2015) Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer. Oncotarget 6, 44609-44622.
190. Cheng Q, Feng F, Zhu L, Zheng Y, Luo X, Liu C et al. (2015) Circulating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinoma. Sci. Rep. 5, 16103.
191. Zheng F, Liao YJ, Cai MY, Liu TH, Chen SP, Wu PH et al. (2015) Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet. 11, e1004873.
192. Ono S, Oyama T, Lam S, Chong K, Foshag LJ, Hoon DS (2015) A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. Oncotarget 6, 7053-7064.
193. Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL, Yao GL (2014) Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis. World J. Gastroenterol. 20, 6906-6911.
194. Lu J, Xu X, Liu X, Peng Y, Zhang B, Wang L et al. (2014) Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br. J. Cancer 110, 392-398.
195. Chen J, Yao D, Li Y, Chen H, He C, Ding N et al. (2013) Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int. J. Mol. Med. 32, 557-567.
196. Kim SY, Jeon TY, Choi CI, Kim DH, Kim DH, Kim GH et al. (2013) Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. J. Mol. Diagn. 15, 661-669.
197. Greenberg E, Besser MJ, Ben-Ami E, Shapira-Frommer R, Itzhaki O, Zikich D et al. (2013) A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study. Biomarkers 18, 502-508.
198. Zhang KC, Xi HQ, Cui JX, Shen WS, Li JY, Wei B et al. (2015) Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis. Am. J. Cancer Res. 5, 821-829.
199. Xu H, Yao Y, Meng F, Qian X, Jiang X, Li X et al. (2015) Predictive value of serum miR-10b, miR-29c, and miR-205 as promising biomarkers in esophageal squamous cell carcinoma screening. Medicine (Baltimore) 94, e1558.
200. Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B et al. (2014) Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 74, 5758-5771.
201. Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y et al. (2012) Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 31, 3513-3523.
202. Yamada N, Tsujimura N, Kumazaki M, Shinohara H, Taniguchi K, Nakagawa Y et al. (2014) Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim. Biophys. Acta 1839, 1256-1272.
203. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T (2013) Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J. Biol. Chem. 288, 10849-10859.
204. Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU et al. (2012) Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 118, 2603-2614.
205. Li J, Zhang Y, Liu Y, Dai X, Li W, Cai X et al. (2013) Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J. Biol. Chem. 288, 23586-23596.
206. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC et al. (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346-5356.
207. Hood JL, San RS, Wickline SA (2011) Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801.
208. Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014-1022.
209. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E et al. (2011) miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20, 104-118.
210. Xu H, Cheung IY, Guo HF, Cheung NK (2009) MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res. 69, 6275-6281.
211. Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J et al. (2013) miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem. Biophys. Res. Commun. 431, 610-616.
212. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S et al. (2012) TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22, 291-303.
213. Muller L, Mitsuhashi M, Simms P, Gooding WE, Whiteside TL (2016) Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci. Rep. 6, 20254.
214. Lundholm M, Schroder M, Nagaeva O, Baranov V, Widmark A, Mincheva-Nilsson L et al. (2014) Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS ONE 9, e108925.
215. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714.
216. Suzuki HI, Miyazono K (2011) Emerging complexity of microRNA generation cascades. J. Biochem. 149, 15-25.
217. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG et al. (2008) Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172-3183.
218. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843.
219. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13, 272-286.
220. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405-414.
221. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087-3095.
222. Tagawa H, Seto M (2005) A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19, 2013-2016.
223. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50.
224. Yamakuchi M, Lowenstein CJ (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8, 712-715.
225. Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199.
226. Pulikkan JA, Peramangalam PS, Dengler V, Ho PA, Preudhomme C, Meshinchi S et al. (2010) C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116, 5638-5649.
227. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443.
228. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y et al. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68, 4123-4132.
229. Blow MJ, Grocock RJ, van Dongen S, Enright AJ, Dicks E, Futreal PA et al. (2006) RNA editing of human microRNAs. Genome Biol. 7, R27.
230. Luciano DJ, Mirsky H, Vendetti NJ, Maas S (2004) RNA editing of a miRNA precursor. RNA 10, 1174-1177.
231. Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT et al. (2012) Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. J. Clin. Invest. 122, 4059-4076.
232. Schmittgen TD (2008) Regulation of microRNA processing in development, differentiation and cancer. J. Cell Mol. Med. 12, 1811-1819.
233. Silva J, Garcia V, Zaballos A, Provencio M, Lombardia L, Almonacid L et al. (2011) Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur. Respir. J. 37, 617-623.
234. Shen J, Wang A, Wang Q, Gurvich I, Siegel AB, Remotti H et al. (2013) Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Cancer Epidemiol. Biomark. Prev. 22, 2364-2373.